ARV Program Management Issues in Low Resource Settings:
A Training Seminar for Policy Makers and Program Managers
---------------------------------------------------------
8 - 19 August, 2005
Hosts: WHO Collaborating Center in Pharmaceutical Policy / Bos-
ton University School of Public Health, Boston MA, USA
**PLEASE NOTE**
Student Visas are not required for the conference.
Course Objectives
Funding through Global Fund, PEPFAR, and other initiatives has
recently transformed AIDS into a treatable disease in developing
and transitional countries. Resources such as ARVs and diagnos-
tics are now available; however, rapid scale-up of AIDS treat-
ment programs has not occurred, in part, due to ARV drug manage-
ment issues. ARV drug management issues include difficulties
with pharmaceutical supply systems and logistics as well as in-
sufficient attention paid to ARV adherence.
Seminar Overview/Course Content
Week One (August 8-12, 2005): Drug Management Key Issues
A description of the various national and international players
involved in ARV management will be discussed with recommenda-
tions to efficiently coordinate efforts. Specific drug manage-
ment issues to be covered include: quantification, procurement,
pricing, quality assurance, and pre-qualification of suppliers.
Week 2 (August 15-19, 2005): ARV Adherence
An overview of adherence issues will be followed by instruction
on how to measure ARV adherence. Approaches to improve adherence
to AIDS and other chronic diseases will be presented. A field
visit to an ARV adherence clinic will allow participants an op-
portunity and interact with health care practitioners (pharma-
cists, physicians, nurses, social workers, nutritionists) in-
volved in ARV adherence activities.
Who Should Attend?
Policy makers, ARV Program Managers, and NGO Officials responsi-
ble for national and local programs. Social scientists, pharma-
cists, and other public health professionals interested in ad-
herence and ARVs.
Teaching Methods/Course Design
Instruction will occur in English. The format will be highly in-
teractive with presentations by international experts followed
by facilitated group exercises and discussion. Case studies and
guided readings will be provided and substantial preparation is
required for each session. A field visit to an ARV Adherence
Clinic will be arranged.
Faculty
Brenda Waning, Boston University School of Public Health; Libby
Levison, Pharmaceutical Consultant;
Richard Laing, World Health Organization, Geneva; Michael Mon-
tagne, Mass. College of Pharmacy; Warren Kaplan, Boston Univer-
sity School of Public Health
Training Costs
Conference costs (no academic credit): US$ 1,225 includes tui-
tion and materials fee. For those who wish to obtain academic
credit (2 credits) for the course, the cost is US$ 1,974.
For more information, contact
Sarah Petty
Tel.: +1-617-638-5234
mailto:ih@bu.edu